Global Insulin Antidiabetics Market 2012-2016
NEW YORK, March 7, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
TechNavio's analysts forecast the Global Insulin Antidiabetics Market 2012-2016 to grow at a CAGR of 12.25 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in diabetic population. The Global Insulin Antidiabetics market has also been witnessing the trend of an increase in awareness and education. However, the increase in use of complementary and alternative medicine could pose a challenge to the growth of this market.TechNavio's report, the Global Insulin Antidiabetics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, and the EMEA and APAC regions; it also covers the Global Insulin Antidiabetics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this market space are Novo Nordisk A/S, Sanofi S.A, and Eli Lilly and Co. Key questions answered in this report: What will the market size be in 2016 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? You can request one free hour of analyst time when you purchase this report. Details provided within the report. TechNavio's research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts